The use of PSA testing as a screening tool for prostate cancer is limited by its low specificity. New data offer insight into how genotypic information might be incorporated into PSA screening approaches to enhance their accuracy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Palmer, L. J. & Cardon, L. R. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 366, 1223–1234 (2005).
Witte, J. S. Prostate cancer genomics: towards a new understanding. Nat. Rev. Genet. 10, 77–82 (2009).
Loeb, S. et al. Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level. J. Urol. 182, 101–104 (2009).
Andriole, G. L. et al. Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 360, 1310–1319 (2009).
Schroder, F. H. et al. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 360, 1320–1328 (2009).
Brown, E. Jr. Screening for prostate cancer with the prostate-specific antigen test, United States, 2002. Statistical Brief #42 (Agency for Healthcare Research and Quality, Rockville, MD, 2004).
Risk, M. C. & Lin, D. W. New and novel markers for prostate cancer detection. Curr. Urol. Rep. 10, 179–186 (2009).
Barnholtz-Sloan, J. S., McEvoy, B., Shriver, M. D. & Rebbeck, T. R. Ancestry estimation and correction for population stratification in molecular epidemiologic association studies. Cancer Epidemiol. Biomarkers Prev. 17, 471–477 (2008).
Draisma, G. et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J. Natl Cancer Inst. 101, 374–383 (2009).
Welch, H. G. & Albertsen, P. C. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J. Natl Cancer Inst. 101, 1325–1329 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Wright, J., Lin, D. Prostate cancer risk stratification by genotype and PSA. Nat Rev Urol 6, 641–642 (2009). https://doi.org/10.1038/nrurol.2009.229
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2009.229
